Sfoglia per RIVISTA
BLOOD CANCER JOURNAL
Collezione AOU Novara

  

Items : 9

Breakthrough infections in MPN-COVID vaccinated patients. in Blood cancer journal / Blood Cancer J. 2022 Nov 15;12(11):154. doi: 10.1038/s41408-022-00749-8.

2022
AOU Novara
AOU Città della Salute di Torino
AO Alessandria

Vannucchi AM; Rambaldi A; Benajiba L; Carbonell S; Kulikowska de Na??cz A; Cattaneo D; Bucelli C; Betti S; Curto-Garcia N; Cavalca F; Borsani O; Guenova M; Navas Elorza B; Angona A; Cichocka E; Lopez Abadia E; Carli G; Xicoy Cirici B; Kusec R; Sagues Serrano M; Garcia-Gutierrez V; Sanchez AM; Hernandez-Boluda JC; Griesshammer M; Kiladjian JJ; Bolaños Calderón E; Heidel FH; Magro Mazo E; Quiroz Cervantes K; et alii...

Long-term follow-up of recovered MPN patients with COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Jun 16;11(6):115. doi: 10.1038/s41408-021-00509-0.

2021
AOU Città della Salute di Torino
AOU Novara

Salmoiraghi S; Rambaldi A; Bellosillo B; Guglielmelli P; Koschmieder S; Borsani O; Betti S; Benajiba L; Garrote M; Cavalca F; Curto-Garcia N; Bellini M; Daffini R; Cuevas B; Cattaneo D; Sobas MA; Xicoy Cirici B; Ruggeri M; Angona A; Hernandez-Boluda JC; Lopez Abadia E; De Stefano V; Bonifacio M; Magro Mazo E; Lunghi F; Garcia-Gutierrez V; Navas Elorza B; Benevolo G; Patriarca A; et alii...

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Feb 4;11(2):21. doi: 10.1038/s41408-021-00417-3.

2021
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Vannucchi AM; Betti S; Harrison C; Curto-Garcia N; Cavalca F; Bellini M; Benajiba L; Bellosillo B; Garrote M; Cattaneo D; Daffini R; Guglielmelli P; Cirici BX; Abadia EL; Carli G; Cuevas B; Hernandez-Boluda JC; Koschmieder S; Angona A; Mazo EM; Lunghi F; Patriarca A; Elorza BN; Serrano MS; Carreno-Tarragona G; Sobas MA; Bonifacio M; Cervantes KSQ; et alii...

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. in Blood cancer journal / Blood Cancer J. 2021 Dec 7;11(12):197. doi: 10.1038/s41408-021-00590-5.

2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Cea M; Offidani M; Boccadoro M; Larocca A; Monaco F; Corradini P; Belotti A; Paris L; Grasso M; Aquino S; De Paoli L; Rota-Scalabrini D; Bonello F; Ballanti S; De Sabbata G; Zambello R; Tacchetti P; Cellini C; Patriarca F; Musolino C; Ciccone G; Capra A; Pescosta N; Petrucci MT; Bringhen S; Liberati AM; Mina R; Falcone AP;

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score. in Blood cancer journal / Blood Cancer J. 2021 Apr 12;11(4):73. doi: 10.1038/s41408-021-00464-w.

2021
AOU San Luigi di Orbassano
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Bringhen S; Sonneveld P; Boccadoro M; Musto P; Hájek R; Corradini P; Guglielmelli T; Giuliani N; Aitoro G; Di Raimondo F; Bonello F; Benevolo G; Patriarca F; Innao V; de Fabritiis P; Zambello R; Cascavilla N; Liberati AM; Gaidano G; Petrucci MT; Derudas D; Capra A; Offidani M; Larocca A; D'Agostino M;

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab. in Blood cancer journal / Blood Cancer J. 2020 Sep 16;10(9):92. doi: 10.1038/s41408-020-00358-3.

2020
AOU Città della Salute di Torino
AO Cuneo
AO Alessandria
AOU Novara

Gattei V; Morabito F; Ferrarini M; Gaidano G; Cuneo A; Foà R; Trentin L; Fronza G; Cutrona G; Di Raimondo F; Angeletti I; Bomben R; Neri A; D'Arrigo G; Tripepi G; Vitale C; Al-Janazreh H; Rossi FM; Zucchetto A; Scortechini I; Consoli U; Loseto G; Pietrasanta D; Bossio S; Moia R; Recchia AG; Lucia E; Mendicino F; Vigna E; et alii...

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents. in Blood cancer journal / Blood Cancer J. 2020 Apr 14;10(4):40. doi: 10.1038/s41408-020-0307-4.

2020
AOU Città della Salute di Torino
AOU Novara

Terpos E; Lonial S; De Paoli L; Jaye DL; Belotti A; Offidani M; Oliva S; Giuliani N; Roussou M; Omedé P; Boise LH; Patriarca F; Gavriatopoulou M; Montefusco V; Kaufman JL; Petrucci MT; Kastritis E; Gay F; Joseph NS; Mina R; Boccadoro M; Nooka AK; Dimopoulos MA;

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials. in Blood cancer journal / Blood Cancer J. 2018 Nov 8;8(11):108. doi: 10.1038/s41408-018-0145-9.

2018
AOU Città della Salute di Torino
AOU Novara

Molinari AL; Cavallo F; Ansell SM; Spina M; Rivera CE; Pavone V; Foran JM; Congiu A; King RL; Tucci A; Reeder CB; Inghirami G; Macon WR; Gaidano G; Pederson LD; LaPlant BR; Chiappella A; Castellino A; Ciccone G; Habermann TM; Witzig TE; Vitolo U; Nowakowski GS;

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment. in Blood cancer journal / Blood Cancer J. 2015 Sep 18;5(9):e347. doi: 10.1038/bcj.2015.75.

2015
AOU Città della Salute di Torino
AOU Novara

Lorenzo RD; Girasoli M; Santini V; D'Emilio A; Bocchia M; Lunghi M; Russo-Rossi A; Russo S; Usala E; Bigazzi C; Tiribelli M; Abruzzese E; Nicolini G; Cambrin GR; Intermesoli T; Martino B; Breccia M; Stagno F; Pungolino E; De Vivo A; Castagnetti F; Testoni N; Fogli M; Bergamaschi M; Pregno P; Turri D; Cancelli V; Skert C; Malagola M; et alii...